Researchers, clinicians and start-ups filled up the seminar room when Oslo Cancer Cluster Incubator together with the Norwegian Industrial Property Office (Patentstyret) and Inven2 invited to a breakfast meeting on June 18th. The breakfast seminar had a special focus on protecting oncology innovations.
Some take-home-messages from the seminar:
- Patents give you negotiation power, and is probably the biggest income source for Norwegian biotech start-ups.
- Never publish anything on what you might wish to patent: Not even talk about it in a public meeting.
- Researchers at University of Oslo and Oslo University Hospital: As soon as you think you have an innovation that could be patented, please contact Inven2 for advice.
Researchers at other universities/university hospitals should contact their TTO`s.
All the presentations from the Oslo Cancer Cluster Incubator breakfast meeting may be downloaded below:
- Welcome and latest update from Oslo Cancer Cluster Incubator, Ketil Widerberg, General Manager, Oslo Cancer Cluster
- Why is it important to protect your oncology innovation? Bjørn Lillekjendlie, Director Patent department, Norwegian Industrial Property Office (Patentstyret)
- What can be patented, how to proceed and what is absolutely crucial in the process? Elen Margrethe Brendeford, Patent examiner, Norwegian Industrial Property Office
- How Inven2 work with securing IPR: strategies and challenges in the field of oncology, Kirsten Stangeby, IPR Manager and Mohammed Amarzguioui, Technology Strategy Manager, both at Inven2.